Tom Riffelmacher
@tom-riffel.bsky.social
860 followers 320 following 32 posts
Professor; University of Cologne; We research Immunometabolism, unconventional T cells, and cardio-oncology.
Posts Media Videos Starter Packs
Reposted by Tom Riffelmacher
pathogenomenick.bsky.social
A bit like spiralling publication costs we need to start having a proper discussion around lab equipment servicing costs. These are often completely disproportionate to the cost of instrument and the service that is provided and seem to serve as a cash cow for vendors.
tom-riffel.bsky.social
Awesome science creativity podcast
@nightsciencepod.bsky.social
itaiyanai.bsky.social
'Both competition and cooperation' – that is an underlying principle of how Google designed its "AI co-scientist" platform to generate ideas and think like a scientist. We talk with the leaders of this project on the latest episode of the Night Science Podcast. @nightsciencepod.bsky.social
Reposted by Tom Riffelmacher
Reposted by Tom Riffelmacher
lji.org
"Immunometabolism, the intersection of cellular metabolism and immune function, has revolutionized our understanding of T cell biology."

LJI experts share key discoveries from the growing field of immunometabolism! 👇 #Tcells #Cd1Mr12025
Reposted by Tom Riffelmacher
immunoboys.bsky.social
Horisberger et al separate Lupus nephritis patients in 3 groups by blood:
healthy-like, interferon-dominant and CD8 T cell-dominant.
The CD8 T cell-dominant group had the highest biopsy activity score and highest response rate after 1 year; the healthy-like the most chronic damage. 🧪 ⑂ #NephSky
1/
Reposted by Tom Riffelmacher
jimmunol.bsky.social
In this #TopRead article, data demonstrated that TNFR family member CD27 is a metabolic regulator in activated human CD4+ cells, suggesting its essential contribution to T-cell metabolism and its relevance as a therapeutic target. Read more in The JI: ow.ly/bCJk50WJAwi.
Reposted by Tom Riffelmacher
dgfi-yi.bsky.social
First session featuring our DGfI study groups ✅ covering innate immunity, autoimmunity, solid tumor immunology, trained immunity and CNS. Much food for thought and discussion during the coffee break☕☕☕ #IUIS25 @dgfi-org.bsky.social
tom-riffel.bsky.social
Good luck with the startup!
Reposted by Tom Riffelmacher
nanaborsa.bsky.social
Bittersweet farewell weeks at @kiroxford.bsky.social, a place pivotal to my growth as an independent scientist. With deep gratitude for this chapter, I'm thrilled to begin the next at @unibas.ch @biomedizin.unibas.ch, where my lab will study organelle inheritance in T cells in the context of ageing.
tom-riffel.bsky.social
MTA/BTA Stelle zu besetzen bei uns im lab! Join us!
Reposted by Tom Riffelmacher
insight.jci.org
In diabetic retinopathy, microvascular damage & inflammation disrupt the blood-retina barrier, but the role of microglia was unclear

Thomas Langmann & team now show suppression of microglia-driven inflammatory responses preserves retinal integrity.

buff.ly/2k5pD5W
Reposted by Tom Riffelmacher
lydialynch.bsky.social
This was a labor of love requiring lots of teamwork over years, repeating in 3 locations! Thanks to all the lab over the years, giving their time generously to this team project, & our wonderful collaborators. The source of fat matters for anti-tumor immunity 🐄🐖🧈🌴🫒🥥
www.nature.com/articles/s42...
The source of dietary fat influences anti-tumour immunity in obese mice - Nature Metabolism
This study shows that animal-based high-fat diets accelerate tumour growth and impair anti-tumour response to melanoma in obese mice, whereas plant-based high-fat diets do not.
www.nature.com
tom-riffel.bsky.social
Same! solving IT “issues”, like accessing university email, are my small daily wins in those days
Reposted by Tom Riffelmacher
tcellogic.bsky.social
Forget Trump & Musk's bromance...join us at Keystone's Immunometabolism Across Scales: From Cells to Systems to Healthspan!
Super science, discussions and colleagues. Be there- Vancouver, BC Jan 11-14, 2026. Keynotes: Amazing Drs. Dana Pe'er and Marcia Haigis!! Speaker line-up is GOAT!
tom-riffel.bsky.social
Openness guides discovery
tom-riffel.bsky.social
Thank you! Sad that I missed your talk on wednesday.
Reposted by Tom Riffelmacher
lji.org
A huge congratulations to LJI's Dr. Tom Riffelmacher! Tom's work has helped reveal a whole new side of T cells, and we are thrilled to see what he does next! 🎉
tom-riffel.bsky.social
I am not dreaming, it’s official! I am starting my lab as Professor in the department of medicine III at @unicologne.bsky.social
We will explore the immunometabolic control of unconventional lymphocytes in cancer and cardiovascular disease.
WE ARE HIRING AT ALL LEVELS (MTA/BTA, postdoc, PHD)
Reposted by Tom Riffelmacher
hsph.harvard.edu
With nearly all of Harvard Chan School’s direct federal grants terminated, we are relying on philanthropy to power our research and support our educational programs. Every gift, regardless of size, advances our vision of health, dignity, and justice for every human. Support our work: hsph.me/whygive
tom-riffel.bsky.social
Thanks, Reika :) I will miss @lji.org
tom-riffel.bsky.social
I am not dreaming, it’s official! I am starting my lab as Professor in the department of medicine III at @unicologne.bsky.social
We will explore the immunometabolic control of unconventional lymphocytes in cancer and cardiovascular disease.
WE ARE HIRING AT ALL LEVELS (MTA/BTA, postdoc, PHD)